Scholarly Index
Filip Jankú
The University of Texas MD Anderson Cancer Center; 26,462 total citations; 667 total publications; best world rank #47
The University of Texas MD Anderson Cancer Center
26,462Total citations
667Total publications
79H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Treatments and Mutations | Lifetime | 269 | US 141 | 99.29 |
| Cancer Genomics and Diagnostics | Lifetime | 337 | US 198 | 99.35 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 109 | US 64 | 98.97 |
| Colorectal Cancer Treatments and Studies | Lifetime | 351 | US 165 | 98.90 |
| Advanced Breast Cancer Therapies | Lifetime | 163 | US 80 | 98.58 |
| Cancer Research and Treatments | Lifetime | 452 | US 267 | 97.59 |
| Melanoma and MAPK Pathways | Lifetime | 213 | US 114 | 97.64 |
| Histone Deacetylase Inhibitors Research | Lifetime | 778 | US 357 | 93.76 |
| Histiocytic Disorders and Treatments | Lifetime | 345 | US 167 | 92.47 |
| Cancer Genomics and Diagnostics | 2021-2025 | 196 | US 93 | 98.44 |
| Cancer Research and Treatments | 2021-2025 | 47 | US 13 | 96.70 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 335 | US 83 | 92.69 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 55 | US 32 | 91.85 |
| Cancer-related Molecular Pathways | 2021-2025 | 233 | US 96 | 89.23 |
| Melanoma and MAPK Pathways | 2021-2025 | 300 | US 101 | 85.76 |